News

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...
The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...
Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...
Researchers develop a self-regulating mRNA medicine that adjusts protein production based on disease-related signals. A research team from The University of Osaka and Institute of Science Tokyo ...
Our study progresses from the rational design of polyplex micelles to the mechanistic elucidation of mRNA degradation, revealing RNase infiltration—rather than carrier dissociation—as the ...
It will combine Ethris’ advanced technology platforms with Thermo Fisher’s good manufacturing practice-compliant manufacturing capabilities. Ethris CEO Carsten Rudolph stated: “Thermo Fisher ...
The big advantage of using mRNA to create vaccines over the traditional method is that vaccines can be made much more quickly, typically within weeks of a new virus being identified. The old method, ...